Professional Marketing briefs: November 2012

Share this article:
Plavix ceded 90% of its market share to generics within two months
Plavix ceded 90% of its market share to generics within two months

Targacept announced on October 8 that its April layoff of 65 employees was not its last—the company will slim its workforce by another 38%, leaving it with 43 employees. The company plans on closing its lab operations by the end of the year. The company has had a number of recent setbacks, which include having to scrap an antidepressant it was developing with AstraZeneca.

Plavix and Avapro deals continue—even though the US patents for both drugs have lapsed. The latest deal is that Bristol-Myers Squibb is returning most of its ­Plavix rights to Sanofi, while holding onto its rights in the US and Puerto Rico. The deal gives BMS a royalty cut on both branded and unbranded Plavix sales worldwide (except for in the US) as well as on branded and unbranded Avapro sales worldwide.

Merck is planning to move its headquarters from Whitehouse Station to Summit, NJ. As a result of that change, the company will be shuttering the Whitehouse location. The proposed move will start in 2014 and is expected to be completed by mid-2015. The company expects the 2,000 Whitehouse employees will be distributed among the company's other locations.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?